LSTM News

News, impact and engagement roundup

News

17 November 2026

Stay up to date with the latest news from Liverpool School of Tropical Medicine. From ground-breaking research to expert commentary, community engagement to academic excellence, this roundup condenses highlights from across our LSTM community.

Higher vitamin B12 levels in both parents may be associated with lower risk of birth defects

Dr Duolao Wang was co-corresponding author on a paper published in Annals of Internal Medicine which explores the association between B12 levels in parents and the risk of birth defects.

The paper – β€˜Periconception Parental Red Blood Cell Folate, Vitamin B12, and Birth Defects in Offspring: A Prospective Cohort Study’ – found that higher parental vitamin B12 levels before conception and higher maternal red blood cell folate concentrations after conception were associated with a lower risk of birth defects in babies.

Dr Wang worked with researchers from the Children’s Hospital of Fudan University to assess 3,032 couples from the Shanghai Preconception Cohort.

The team measured vitamin B12 and folate levels and examined their relationship with birth defects identified among live births, stillbirths and pregnancies ending because of fetal abnormalities.

Their findings suggest that the nutritional status of both parents around the time of conception may play a role in preventing birth defects, supporting the potential importance of both paternal and maternal nutrition during the periconceptional period and early pregnancy.

Dr Duolao Wang

LSTM celebrates launch of North West Policy Partnership

Liverpool School of Tropical Medicine joined universities from across the region at the launch of the new North West Policy Partnership (NWPP), supported by Universities Policy Engagement Network (UPEN).

The new network, led by Manchester Metropolitan University’s policy think tank MetroPolis in partnership with LSTM, brings together researchers, policymakers and practitioners to improve policymakers’ access to research and evidence.

Member institutions will enable policymakers to gain a better understanding of the challenges being faced across the North West’s communities, providing them with the expertise they need to ensure evidence-based decision-making.

LSTM representatives were joined by Professor Chris Johnson and Tim Kay, chief and deputy chief scientific advisors for the Department for Business, Innovation, Science and Trade (DBIST), who led roundtable discussions and shared the Department’s priorities.

Professor Johnson said: β€œThe NWPP launch event was a fantastic opportunity to connect with so many skilled and knowledgeable researchers in the region and to kick start a lasting relationship between DBIST and NWPP that will ensure policy benefits from expertise in the North West.”

A group of people sit around a large table in a high-ceilinged room.

Malawi-Liverpool-Wellcome Research Programme researcher awarded fellowship for global R&D programme

Arthur Vengesai has been selected as a recipient of a sub-Saharan Africa Health Research and Innovation (SAHRI) Fellowship as part of a programme to advance Africa’s future in infectious disease research leadership.

Arthur, postdoctoral research associate on the LifeArc-funded β€˜dried spots’ and NIHR-funded VacAMR projects, was commended for his commitment to advancing translational research.

Dr Brenda Kwambana said: β€œThis is such fantastic news for Arthur and a well-deserved reward for the hard work and dedication he has shown.

β€œWe also want to acknowledge the incredible support from LSTM Enterprise and Innovation over the years. Arthur has learned a great deal from the team, which has been key to his success.”

The SAHRI Fellowship Programme, a three-year initiative to support 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa, aims to develop future leaders in biomedical innovation and clinical research to address the continent’s most pressing infectious disease challenges.

Arthur will receive advanced research and development training in tropical medicine and biotech, and undertake an internship at BioNTech in Germany and hands-on placements at one of the leading Africa-based biotech institutes, before returning to Malawi to boost MLW’s work with his new expertise.

Malawi Liverpool Wellcome
A head and shoulders shot of Arthur smiling.

Collaboration with Noul to advance AI-assisted malaria diagnostics

LSTM and diagnostics company Noul are working together to evaluate a new generation of AI-assisted malaria diagnostics.

The project will improve diagnostic accuracy, consistency and standardisation, the complete malaria microscopy workflow.

The partnership, which began in December 2025, brings together LSTM’s internationally recognised expertise in malaria diagnostics with Noul’s innovative approach to workflow automation.

Collaboration has included testing the milab MAL platform, designed to automate and streamline blood film preparation and analysis, supporting more consistent and standardised slide review.

Jayne Jones, Unit Manager for Clinical Sciences, said: β€œWorking with miLab MAL has provided an opportunity to evaluate how AI-assisted digital microscopy may support malaria diagnosis within a specialist reference laboratory.

β€œThe collaboration has generated valuable discussion around workflow integration, usability and the future role of digital microscopy in malaria diagnostics.”

Enterprise and Innovation Unit
Scientist wearing a white lab coat and blue gloves assists a microscope.